Zhengting Chen
Kunming, 650118, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
COX7A2L drives lung adenocarcinoma progression and radioresistance via PI3K/AKT signaling.
Journal: Life sciences
Published: February 25, 2026
The infratentorial localization of brain metastases in non-small cell lung cancer indicates poorer prognosis and a distinct selection of radiotherapy.
Journal: Neoplasma
Published: August 01, 2025
ZIP10 drives radioresistance and malignant progression in lung adenocarcinoma by inhibiting the Hippo pathway via a Zinc-LATS axis.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 15, 2025
High-Dose Ascorbic Acid Combined With Dihydroartemisinin Inhibits Lung Adenocarcinoma Malignancy by Inducing Ferroptosis via SLC7A11/GPX4 Pathway.
Journal: Journal of cellular and molecular medicine
Published: February 25, 2025
Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1-4 brain metastases.
Journal: BMC cancer
Published: June 12, 2022
Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures.
Journal: Frontiers in oncology
Published: February 15, 2022
Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.
Journal: Technology in cancer research & treatment
Published: May 12, 2021
G9a Regulates Cell Sensitivity to Radiotherapy via Histone H3 Lysine 9 Trimethylation and CCDC8 in Lung Cancer.
Journal: OncoTargets and therapy
Published: December 11, 2020
LINC00152 is a potential biomarker involved in the modulation of biological characteristics of residual colorectal cancer cells following chemoradiotherapy.
Journal: Oncology letters
Published: April 25, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026